Understanding HIV and AIDS: Causes and Impact on the Immune System

Human Immunodeficiency Virus (HIV) is a retrovirus that attacks the immune system, specifically CD4+ T-helper cells. Without treatment, it progresses to Acquired Immunodeficiency Syndrome (AIDS), the late stage defined by severe immune damage (CD4 <200 cells/μL) or opportunistic infections/cancers.

How HIV Weakens Immunity

  • HIV binds to CD4 receptors on T-cells, macrophages, dendritic cells.
  • Viral RNA is reverse-transcribed into DNA, integrated into host genome.
  • Infected cells produce new virions, leading to cell death and chronic immune activation.
  • Progressive CD4 decline impairs cellular and humoral immunity, leaving the body vulnerable to infections (TB, pneumocystis, CMV, fungal) and malignancies (lymphoma, Kaposi sarcoma).

Transmission

Sexual contact, blood exposure (needles, transfusions), mother-to-child (pregnancy, birth, breastfeeding). Not transmitted by casual contact, saliva, sweat, insects, air, water.

Modern Management

Antiretroviral Therapy (ART)—combination of 3+ drugs—suppresses viral replication to undetectable levels (<50 copies/mL). This halts immune destruction, allows CD4 recovery, prevents transmission (U=U: Undetectable = Untransmittable), and enables near-normal life expectancy. Early diagnosis and lifelong adherence are critical.

Prevention

  • Pre-Exposure Prophylaxis (PrEP): daily oral tenofovir/emtricitabine or injectable cabotegravir for high-risk individuals.
  • Post-Exposure Prophylaxis (PEP): 28-day ART started within 72 hours of exposure.
  • Condoms, sterile needles, treatment as prevention, prenatal ART.

Viral Infections - Related Articles